Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2003
09/18/2003US20030175986 Using fluorescent compound to analysis protein complexes; determination of genome sequence
09/18/2003US20030175985 Method for measuring substance and testing piece
09/18/2003US20030175984 Using dye; colorimetric analysis; forming insoluble compound
09/18/2003US20030175982 Using gamma rays
09/18/2003US20030175981 Antenatal screening for Down's syndrome
09/18/2003US20030175980 Ribbon flow cytometry and cell sorting
09/18/2003US20030175978 Test strip qualification system
09/18/2003US20030175960 Isolation, cloning of genes; anticancer agents, autoimmune disease; genetic engineered cells immobilized with hyaluronic acid
09/18/2003US20030175959 Genetically engineered skin cell types and toxicity assays
09/18/2003US20030175958 Methods for using bag expression as a cell differentiation agent and marker
09/18/2003US20030175957 Pre-adipose cell lines
09/18/2003US20030175953 Immortalized vascular adventital cell line
09/18/2003US20030175946 Biosensor
09/18/2003US20030175945 Measuring, analyzing surface of sampling; determination work function; generating configuration images
09/18/2003US20030175939 Diagnosis, therapy cancer; genetic engineering
09/18/2003US20030175934 Controlling cell differentiation, cell proliferation; anticancer agents
09/18/2003US20030175921 Complexing antigen, antibodies; immunoassay
09/18/2003US20030175895 Chemokine
09/18/2003US20030175894 Chemokine alpha-6
09/18/2003US20030175880 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175879 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175878 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175877 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175876 a neurotrophin with biological activity on the central/peripheral nervous system cells; used for treating GDNF-responsive conditions such as alzhiemer's, parkinsons; device for nerve damage treatment
09/18/2003US20030175875 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175874 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175873 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175872 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175871 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175870 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175869 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175868 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175867 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175866 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175865 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175859 Fluorescent proteins
09/18/2003US20030175858 Of given sequence; diagnostic and therapeutic methods useful for treating unspecified diseases, disorders, and/or conditions related to the proteins
09/18/2003US20030175852 Ehancement of in situ hybridization
09/18/2003US20030175850 Devices and methods for isolating target cells
09/18/2003US20030175849 Identifying compounds for treating vision defects associated with intraocular pressure
09/18/2003US20030175848 For use as alternative substrates for NAD(P)H-dependent disulphide-reductase enzymes such as trypanothion reductase and thioredoxine reductase
09/18/2003US20030175845 Use of sulfitolysis in high performance peptide mapping
09/18/2003US20030175844 Electroblotting through digestion membrane then analyzing with mass spectrometry; proteases (trypsin); matrix assisted laser desorption
09/18/2003US20030175843 Reagent, method and apparatus for measuring amylase activity
09/18/2003US20030175840 Kit which detects ligand associated with nuclear factor kappa beta receptor for treating toxic shock, sepsis, inflammation and graft vs host disease
09/18/2003US20030175839 Detecting and quantifying antihemophlic factors in blood using plasminogin activators; anticoagulants
09/18/2003US20030175838 Comprises dioxetane compound and phosphatases
09/18/2003US20030175836 Detection of molecular interactions by beta-lactamase reporter fragment complementation
09/18/2003US20030175835 Gram-negative negative bacteria such as pasteurella trehalosi and/or mannheimia haemolytica for diagnosis and treatment of respiratory disorders in animals; veterinary medicine; genetic vaccines
09/18/2003US20030175833 Packaged pharmaceuticals and methods for causing compounds and pharmaceutical compositions to be used as inhibitors of neoplastic lesions
09/18/2003US20030175832 Diagnosing nervous system disorder via presence of aberrant macrophages in blood
09/18/2003US20030175831 Monoreagent for assaying platelet-derived microparticles
09/18/2003US20030175828 Signal amplification by Hybrid Capture
09/18/2003US20030175827 Lypholized microarray comprising immobilized polypeptide for proteomic analysis
09/18/2003US20030175826 Which have acrylic amide polymer immobilized thereto; heat shock proteins
09/18/2003US20030175823 Method of screening remedy for heart failures
09/18/2003US20030175822 Opiate, cannabinoid, and estrogen receptors
09/18/2003US20030175820 Flow immunoassay assembly with multiple flow channels
09/18/2003US20030175819 Methods for identifying modulators of apoptosis
09/18/2003US20030175818 Devices and methods for isolating and recovering target cells
09/18/2003US20030175817 Method of screening for antiandrogen agent
09/18/2003US20030175815 Determining whether fluorescently labeled compound is phosphorylated via monitoring/measuring shift in polarized fluorescence
09/18/2003US20030175814 Using monclonal antibody to monitor binding at leukointegrin receptor (LFA-1)
09/18/2003US20030175813 For high-throughput screening of combinatorial libraries
09/18/2003US20030175812 Using three dimensional liposome-polydiacetylene microarrays for detecting preferential particles in sample
09/18/2003US20030175811 Organ transplant rejection and associated conditions
09/18/2003US20030175810 Detecting nucleotide binding protein modulators which effect activity of G protein-coupled receptors (P2Y); bioassays
09/18/2003US20030175807 Chimeric GFP-aequorin as bioluminescent Ca+at the single cell level
09/18/2003US20030175805 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering
09/18/2003US20030175804 Macromolecule detection
09/18/2003US20030175803 Assay buffer, compositions containing the same, and methods of using the same
09/18/2003US20030175802 Method for determining the biologically effective parathyroid hormone activity in a sample
09/18/2003US20030175799 Comprises stable amino acid sequence scaffold which mimics native protein structures and interactions; drug screening and design
09/18/2003US20030175790 High throughput screening for detecting modulators of molecular interaction and cellular processes
09/18/2003US20030175782 Detection chips for monitoring gene expression, gene representation or restriction fragment length polymorphisms
09/18/2003US20030175779 Preparing solid support comprising immobilized biopolymers for detecting, measuring, separating and/or assaying DNA or proteins in a sample
09/18/2003US20030175775 Ligand for G-protein coupled receptor GPR43 and uses thereof
09/18/2003US20030175774 Single-tube, ready-to-use assay kits and methods using same
09/18/2003US20030175773 Encoding and decoding of array sensors utilizing nanocrystals
09/18/2003US20030175769 Reagents for improved PCR
09/18/2003US20030175766 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
09/18/2003US20030175764 Monitoring interleukin allelic expression to detect occlusive, fragile plaque, restenosive and atherscerotic disorders
09/18/2003US20030175760 Identifying immunotoxin for treatment of cancers; antitumor/antiproliferative/anticarcinogenic agents
09/18/2003US20030175759 Using electrophoresis and restriction fragment length polymorphisms to identify preferential nucleotide sequences in data base
09/18/2003US20030175753 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling
09/18/2003US20030175750 Identifying one or more of a plurality of sequences differing by one or more single-base changes; restriction fragment length polymorphisms
09/18/2003US20030175747 Microfluidic apparatus for detection, separation and classification multiple DNA sequences; restriction fragment length polymorphisms
09/18/2003US20030175746 Using oligonucleotide primers complimentary to virulence determinant genes (VDG) for classifying, identifying and diagnosing campylobacter infection
09/18/2003US20030175744 Replication primer sequences for identifying ligand-binding domains for detection of neuron odorants, toxic odors and which can be used to manipulate odor response in animals
09/18/2003US20030175742 Comprises pyrene, perylene, coronene, and/or rubrene groups; solid phase synthesis; for DNA analysis; fluorescent in situ hybridization (FISH)
09/18/2003US20030175741 PCP-administered (phencyclidine/angel dust) chronic animal models; drug screening
09/18/2003US20030175737 Quantifying target molecules contained in a liquid
09/18/2003US20030175736 Classifying and characterizing prostate gland tissues via monitoring expression of tumor markers such as, hepsin, pim-1, ezh2 or alpha-methylacyl-coa racemase for diagnosing prostate/urogenital health
09/18/2003US20030175725 Mycobacterial diagnostics
09/18/2003US20030175720 Cluster analysis of genetic microarray images
09/18/2003US20030175719 Random array of micro-spheres for the analysis of nucleic acid using enzyme digestion
09/18/2003US20030175718 Identifying biomolecules bound to electrode/semiconductor comprised of titania
09/18/2003US20030175717 Apparatus and method for predicting treatment response of cancer
09/18/2003US20030175713 Method for diagnosis of inflammatory diseases using CALGRANULIN C
09/18/2003US20030175706 Using oligonuclelotide probes for rapid, automated detection of infectious pathogenic agents as well as wild type and mutant gene expression
1 ... 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 ... 3937